195 related articles for article (PubMed ID: 25775012)
1. Enhanced oral bioavailability of paclitaxel by solid dispersion granulation.
Shanmugam S; Im HT; Sohn YT; Kim YI; Park JH; Park ES; Woo JS
Drug Dev Ind Pharm; 2015; 41(11):1864-76. PubMed ID: 25775012
[TBL] [Abstract][Full Text] [Related]
2. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
[TBL] [Abstract][Full Text] [Related]
3. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
[TBL] [Abstract][Full Text] [Related]
4. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q
Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.
Yang FH; Zhang Q; Liang QY; Wang SQ; Zhao BX; Wang YT; Cai Y; Li GF
Molecules; 2015 Mar; 20(3):4337-56. PubMed ID: 25756651
[TBL] [Abstract][Full Text] [Related]
7. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel.
Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D
Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550
[TBL] [Abstract][Full Text] [Related]
8. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.
Miller DA; Keen JM; Brough C; Ellenberger DJ; Cisneros M; Williams RO; McGinity JW
J Pharm Pharmacol; 2016 May; 68(5):678-91. PubMed ID: 26454138
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Patel K; Patil A; Mehta M; Gota V; Vavia P
Int J Pharm; 2014 Sep; 472(1-2):214-23. PubMed ID: 24954663
[TBL] [Abstract][Full Text] [Related]
12. A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats.
Piao H; Yang L; Piao H; Wang P; Shi H; Fang L; Cui F
Drug Dev Ind Pharm; 2016; 42(3):353-63. PubMed ID: 26161937
[TBL] [Abstract][Full Text] [Related]
13. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
[TBL] [Abstract][Full Text] [Related]
14. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.
Ganta S; Devalapally H; Amiji M
J Pharm Sci; 2010 Nov; 99(11):4630-41. PubMed ID: 20845461
[TBL] [Abstract][Full Text] [Related]
15. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
Lee CK; Choi JS
Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
[TBL] [Abstract][Full Text] [Related]
16. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
Baek JS; So JW; Shin SC; Cho CW
Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
[TBL] [Abstract][Full Text] [Related]
18. Improved bioavailability and antiasthmatic efficacy of poorly soluble curcumin-solid dispersion granules obtained using fluid bed granulation.
Jang DJ; Kim ST; Lee K; Oh E
Biomed Mater Eng; 2014; 24(1):413-29. PubMed ID: 24211923
[TBL] [Abstract][Full Text] [Related]
19. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
Li R; Eun JS; Lee MK
Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
